{"disease":{"id":"prostatic-neoplasm","name":"prostatic neoplasm"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02963675","title":"Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in Sweden","phase":"","overall_status":"COMPLETED","enrollment_count":15953,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT02702908","title":"Second Primary Cancers in Patients With Castration Resistant Prostate Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":6442,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT05520138","title":"Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC)","phase":"","overall_status":"COMPLETED","enrollment_count":5506,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT02546908","title":"A Registry of Participants With Prostate Cancer in Asia","phase":"","overall_status":"COMPLETED","enrollment_count":3644,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT05574647","title":"Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":3600,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT06072196","title":"A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)","phase":"","overall_status":"COMPLETED","enrollment_count":3017,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06046131","title":"Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Guadeloupe","has_results":false},{"nct_id":"NCT05968599","title":"A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":2731,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03767244","title":"A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2517,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT06151418","title":"A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces","phase":"","overall_status":"COMPLETED","enrollment_count":2313,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT02788409","title":"Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the US","phase":"","overall_status":"COMPLETED","enrollment_count":2234,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT01306890","title":"A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":1976,"lead_sponsor_name":"Dendreon","has_results":true},{"nct_id":"NCT02531516","title":"An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1503,"lead_sponsor_name":"Aragon Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT06925737","title":"A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1440,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT07406282","title":"A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics","phase":"","overall_status":"RECRUITING","enrollment_count":1400,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06136650","title":"A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1314,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03879486","title":"Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate Biopsy","phase":"NA","overall_status":"COMPLETED","enrollment_count":1257,"lead_sponsor_name":"Hospital de Transplante Doutor Euryclides de Jesus Zerbini","has_results":false},{"nct_id":"NCT03834493","title":"Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1244,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01946204","title":"A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1207,"lead_sponsor_name":"Aragon Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04720157","title":"An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1145,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03834506","title":"Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1030,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT00923221","title":"Collection of Blood From Patients With Prostate Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT02257736","title":"An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":982,"lead_sponsor_name":"Aragon Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04034095","title":"A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan","phase":"","overall_status":"COMPLETED","enrollment_count":979,"lead_sponsor_name":"Janssen Pharmaceutical K.K.","has_results":false},{"nct_id":"NCT02854982","title":"Impact on Quality of Life 3 Years After Diagnosis of Prostate Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":900,"lead_sponsor_name":"Centre Hospitalier Universitaire de Nīmes","has_results":false},{"nct_id":"NCT03348722","title":"Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer START","phase":"","overall_status":"COMPLETED","enrollment_count":850,"lead_sponsor_name":"Rete Oncologica Piemonte, Valle d'Aosta","has_results":false},{"nct_id":"NCT02043678","title":"Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":806,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT07225946","title":"A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":false},{"nct_id":"NCT03834519","title":"Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":793,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03016312","title":"A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":759,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT05228197","title":"Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":750,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT01618370","title":"Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":705,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03479359","title":"Learning Curve of Digital Rectal Examination for Prostate Cancer Among Internship","phase":"","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT04557059","title":"A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":693,"lead_sponsor_name":"Janssen Pharmaceutica N.V., Belgium","has_results":false},{"nct_id":"NCT00032825","title":"Ketoconazole Plus Docetaxel to Treat Prostate Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":674,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04736199","title":"Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":669,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT03935282","title":"Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors","phase":"NA","overall_status":"COMPLETED","enrollment_count":645,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT04093375","title":"Radical Prostatectomy Versus Radical Radiotherapy for Locally Advanced Prostate Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT04962919","title":"Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":584,"lead_sponsor_name":"Latin American Cooperative Oncology Group","has_results":false},{"nct_id":"NCT02729103","title":"Treatment Patterns in Metastatic Prostate Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":565,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04521894","title":"The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT03805919","title":"Men at High Genetic Risk for Prostate Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04689828","title":"177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":469,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06379880","title":"Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution","phase":"NA","overall_status":"COMPLETED","enrollment_count":411,"lead_sponsor_name":"Centre Paul Strauss","has_results":false},{"nct_id":"NCT03343093","title":"Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors","phase":"NA","overall_status":"COMPLETED","enrollment_count":403,"lead_sponsor_name":"University of Minnesota","has_results":true},{"nct_id":"NCT04398173","title":"Detection Rate of Prostate Cancer in Men Undergoing MRI","phase":"","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Fondazione del Piemonte per l'Oncologia","has_results":false},{"nct_id":"NCT03827616","title":"Moderately Hypofractionated Radiotherapy for Prostate Cancer.","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Tatarstan Cancer Center","has_results":false},{"nct_id":"NCT06579911","title":"Combining High-frequency Micro-ultrasound and Multiparametric MRI Target Biopsy for Detecting Prostate Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Salzburger Landeskliniken","has_results":false},{"nct_id":"NCT03693703","title":"Comparison of Multi-parametric and Bi-parametric Magnetic Resonance Imaging in Men With Suspicion of Prostate Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":391,"lead_sponsor_name":"Fondazione del Piemonte per l'Oncologia","has_results":false},{"nct_id":"NCT02023697","title":"Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":391,"lead_sponsor_name":"Bayer","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}